Marshall Wace, LLP Compugen LTD Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Compugen LTD stock. As of the latest transaction made, Marshall Wace, LLP holds 40,489 shares of CGEN stock, worth $71,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,489
Previous 88,169
54.08%
Holding current value
$71,260
Previous $134,000
55.97%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CGEN
# of Institutions
79Shares Held
16.3MCall Options Held
28.7KPut Options Held
48.3K-
Silverarc Capital Management, LLC2.9MShares$5.1 Million1.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.4MShares$2.46 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.39MShares$2.44 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.05MShares$1.85 Million0.94% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.8 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $152M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...